130 related articles for article (PubMed ID: 4814944)
1. Letter: Methotrexate dosage schedule.
Rees RB
Arch Dermatol; 1974 Mar; 109(3):407. PubMed ID: 4814944
[No Abstract] [Full Text] [Related]
2. Pulmonary and hepatic complications of methotrexate therapy of psoriasis.
Filip DJ; Logue GL; Harle TS; Farrar WH
JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291
[No Abstract] [Full Text] [Related]
3. Liver injury associated with methotrexate therapy for psoriasis.
Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
[No Abstract] [Full Text] [Related]
4. Methotrexate induced liver disease in psoriasis.
Millward-Sadler GH; Ryan TJ
Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
[No Abstract] [Full Text] [Related]
5. [Oral methotrexate therapy: pro and con].
Zachariae H
Hautarzt; 1985 Jan; 36(1):10-2. PubMed ID: 3972575
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate in psoriasis with and without leucovorin: effect of different dosage schedules on acute liver toxicity.
Zachariae H; Bjerring P
Acta Derm Venereol; 1982; 62(5):446-8. PubMed ID: 6183902
[TBL] [Abstract][Full Text] [Related]
7. Use of methotrexate in psoriasis.
Roenigk HH; Maibach HI; Weinstein GD
Arch Dermatol; 1972 Mar; 105(3):363-5. PubMed ID: 5012144
[No Abstract] [Full Text] [Related]
8. Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey.
Nyfors A
Dan Med Bull; 1980 Apr; 27(2):74-96. PubMed ID: 7000451
[No Abstract] [Full Text] [Related]
9. Systemic chemotherapy for psoriasis: a national survey.
Bergstresser PR; Schreiber SH; Weinstein GD
Arch Dermatol; 1976 Jul; 112(7):977-81. PubMed ID: 947151
[TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
Tobias H; Auerbach R
Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
[No Abstract] [Full Text] [Related]
11. Severe liver damage caused by treatment of psoriasis with methotrexate.
Pai SH; Werthamer S; Zak FG
N Y State J Med; 1973 Nov; 73(21):2585-7. PubMed ID: 4518596
[No Abstract] [Full Text] [Related]
12. Hazards of prolonged low-dose methotrexate therapy.
Bender AS
Va Med Mon (1918); 1970 Apr; 97(4):218-9. PubMed ID: 5317468
[No Abstract] [Full Text] [Related]
13. Effects of methotrexate on the liver in psoriasis.
Reese LT; Grisham JW; Aach RD; Eisen AZ
J Invest Dermatol; 1974 Jun; 62(6):597-602. PubMed ID: 4835782
[No Abstract] [Full Text] [Related]
14. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA
Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272
[No Abstract] [Full Text] [Related]
15. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
[No Abstract] [Full Text] [Related]
16. A prospective study of the effects of weekly oral methotrexate on liver biopsy.
Warin AP; Landells JW; Levene GM; Baker H
Br J Dermatol; 1975 Sep; 93(3):321-7. PubMed ID: 1103936
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
[No Abstract] [Full Text] [Related]
18. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Palmer HM
Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
[No Abstract] [Full Text] [Related]
19. Methotrexate pharmacokinetics in psoriatic patients developing hepatic fibrosis.
Jones SK; Aherne GW; Campbell MJ; White JE
Arch Dermatol; 1986 Jun; 122(6):666-9. PubMed ID: 3717976
[TBL] [Abstract][Full Text] [Related]
20. [Experience with methotrexate in the management of psoriasis].
Mazzi R
Dermatologica; 1969; 139(4):298-300. PubMed ID: 5374668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
